Octavio Ramilo, MD, joins us once again to discuss potential benefits of RSV vaccination beyond disease prevention and to explain how to speak with patients about vaccines and uptake.
Octavio Ramilo, MD
Advertisement
Octavio Ramilo, MD, chair of the Department of Infectious Diseases at St. Jude Children’s Research Hospital.
Articles by Octavio Ramilo, MD
Ramilo, a clesrovimab clinical trial investigator, breaks down the recent FDA approval for the newest monoclonal antibody to protect against RSV disease in infants.
Advertisement
Latest Updated Articles
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MDPublished: June 20th 2025 | Updated:
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV preventionPublished: June 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C
2
Health system–based clinical pathway improves pediatric lipid screening rates
3
Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease
4
Environmental distress in children: Recognizing and responding to eco-anxiety
5
